HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.

Abstract
Increased fibrinolysis is an important component of acute promyelocytic leukemia (APL) bleeding diathesis. APL blasts overexpress annexin II (ANXII), a receptor for tissue plasminogen activator (tPA), and plasminogen, thereby increasing plasmin generation. Previous studies suggested that ANXII plays a pivotal role in APL coagulopathy. ANXII binding to tPA can be inhibited by homocysteine and hyperhomocysteinemia can be induced by L-methionine supplementation. In the present study, we used an APL mouse model to study ANXII function and the effects of hyperhomocysteinemia in vivo. Leukemic cells expressed higher ANXII and tPA plasma levels (11.95 ng/mL in leukemic vs 10.74 ng/mL in wild-type; P = .004). In leukemic mice, administration of L-methionine significantly increased homocysteine levels (49.0 μmol/mL and < 6.0 μmol/mL in the treated and nontreated groups, respectively) and reduced tPA levels to baseline concentrations. The latter were also decreased after infusion of the LCKLSL peptide, a competitor for the ANXII tPA-binding site (11.07 ng/mL; P = .001). We also expressed and purified the p36 component of ANXII in Pichia methanolica. The infusion of p36 in wild-type mice increased tPA and thrombin-antithrombin levels, and the latter was reversed by L-methionine administration. The results of the present study demonstrate the relevance of ANXII in vivo and suggest that methionine-induced hyperhomocysteinemia may reverse hyperfibrinolysis in APL.
AuthorsRafael H Jácomo, Barbara A Santana-Lemos, Ana Silvia G Lima, Patricia A Assis, Ana Paula A Lange, Lorena L Figueiredo-Pontes, Luciana O Oliveira, Sarah C Bassi, Mariana T L Benício, Márcia S Baggio, Aglair B Garcia, Roberto P Falcão, Eduardo M Rego
JournalBlood (Blood) Vol. 120 Issue 1 Pg. 207-13 (Jul 05 2012) ISSN: 1528-0020 [Electronic] United States
PMID22517898 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Annexin A2
  • Recombinant Proteins
  • Homocysteine
  • Methionine
  • Tissue Plasminogen Activator
  • Fibrinolysin
Topics
  • Animals
  • Annexin A2 (metabolism, pharmacology)
  • Blood Coagulation (physiology)
  • Bone Marrow Transplantation
  • Disease Models, Animal
  • Fibrinolysin (metabolism)
  • Fibrinolysis (physiology)
  • Homocysteine (blood)
  • Hyperhomocysteinemia (chemically induced)
  • Leukemia, Promyelocytic, Acute (complications, metabolism, pathology)
  • Methionine (pharmacology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Recombinant Proteins (metabolism, pharmacology)
  • Tissue Plasminogen Activator (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: